Zusammenfassung
Patienten mit einer organisch bedingten psychischen Störung zeigen sehr häufig Auffälligkeiten in ihrem „Verhalten“ [ 26, 64, 114, 122, 150]. Diese können für den Betreffenden selbst und/oder für seine Umwelt sehr störend sein. Hierzu zählen v.a.
-
Aggression,
-
Antriebssteigerung/Unruhezustände,
-
Apathie/ Antriebsminderung/psychomotorische Verlangsamung,
-
Schlafstörungen,
-
sexuelle Störungen,
-
Substanzmissbrauch (Alkohol, Medikamente und Drogen),
-
Suizidalität,
-
vegetative Störungen sowie
-
veränderte Nahrungsaufnahme.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aarsland D, Cummings JL, Yenner G, Miller B (1996) Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer’s disease. Am J Psychiatry 153:243–247
Aarsland D, Larsen JP, Cummings JL, Laake K (1999) Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56:595–601
Achermann P, Borbely AA (1992) Combining different models of sleep regulation. J Sleep Res 1:144–147
Ackermann H, Ziegler W (1995) Akinetischer Mutismus - eine Literaturübersicht. Fortschr Neurol Psychiatr 63:59–67
Adler LA, Angrist B, Reiter S, Rotrosen J (1989) Neuroleptic-induced akathisia: a review. Psychopharmacol 97:1–11
Aharon-Peretz J, Harel T, Revach M, Ben-Haim SA (1992) Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer’s disease. Arch Neurol 49:919–922
Aharon-Peretz J, Kliot D, Tomer R (2000) Behavioral differences between white matter lacunar dementia and Alzheimer’s disease: a comparison on the neuropsychiatric inventory. Dement Geriatr Cogn Disord 11:294–298
Allain H, Dautzenberg PH, Maurer K, Schuck S, Bonhomme D, Gerard D (2000) Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment. Psychopharmacology 148:361–366
Alzheimer Europe (1999) Handbuch der Betreuung and Pflege von Alzheimer-Patienten. Thieme, Stuttgart
Ambrozi L, Danielczyk W (1988) Die Behandlung zerebraler Funktionsstörungen mit Memantine bei psychogeriatrischen Patienten - Ergebnisse einer Phase IIDoppelblindstudie. Pharmacopsychiatry 21:144–146
Aminoff MJ (1996) Autonomic nervous system. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, S 93–116
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM-IV). American Psychiatric Association, Washington DC
American Sleep Disorders Association (ASDA) (1990) International classification of sleep disorders: diagnostic and coding manual. Allen Press, Lawrence, Kansas
Andersson S, Gundersen PM, Finset A (1999) Emotional activation during therapeutic interaction in traumatic brain injury: effect of apathy, self-awareness and implications for rehabilitation. Brain Inj 13:393–404
Andersson S, Krogstad JM, Finset A (1999) Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity. Psychol Med 29:447–456
Apter A, Plutchik R, van Praag HM (1993) Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta Psychiatr Scand 87:1–5
Askenasy JJ (1993) Sleep in Parkinson’s disease. Acta Neurol Scand 87:167–170
Association of Sleep Disorders Centers (ASDC) (1979) Diagnostic classification of sleep and arousal disorders. Sleep 2:1–137
Azouvi P, Jokic C, Attal N, Denys P, Markabi S, Bussel B (1999) Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial. Brain Inj 13:797–804
Ballard C, Bannister C, Graham C, Oyebode F, Wilcock G (1995) Associations of psychotic symptoms in dementia sufferers. Br J Psychiatry 167:537–540
Battaglia J, Moss S, Rush J, Kang J, Mendoza R, Leedom L, Dubin W, McGlynn C, Goodman L (1997) Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med 15:335–340
Bazire S (2000) Psychotropic drug directory. Mark Allen Publishing, Wilts
Bedard M-A, Montplaisir J, Richer F, Rouleau I, Malo J (1991) Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol 13:950–964
Bellus SB, Stewart D, Vergo JG, Kost PP, Grace J, Barkstrom SR (1996) The use of lithium in the treatment of aggressive behaviours with two brain-injured individuals in a state psychiatric hospital. Brain Inj 10:849–860
Benca RM, Obermeyer WH, Thisted RA, Gilin C (1992) Sleep and psychiatric disorders - a meta-analysis. Arch Gen Psychiatry 49:651–668
Benoit M, Dygai I, Migneco O, Robert PH, Bertogliati C, Darcourt J, Benoliel J, Aubin-Brunet V, Pringuey D (1999) Behavioral and psychological symptoms in Alzheimer’s disease. Relation between apathy and regional cerebral perfusion. Dement Geriatr Cogn Disord 10:511–517
Bente D (1981) Vigilanzregulation, hirnorganisches Psychosyndrom and Alterserkrankungen: Ein psychophysiologisches Modell. In: Bente D, Coper H, Kanowski S (Hrsg) Hirnorganische Psychosyndrome im Alter. Springer, Berlin, S 63–73
Bhana N, Spencer CM (2000) Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia. Drugs Aging 16:451–471
Bhatia KP, Marsden CD (1994) The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 117:859–876
Bieniek SA, Ownby RL, Penalver A, Dominguez RA (1998) A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 18:57–62
Bliwise DL, Yesavage JA, Tinklenberg JR, Dement WC (1989) Sleep apnea in Alzheimer’s disease. Neurobiol Aging 10:343–346
Blumer D, Walker AE (1975) The neural basis of sexual behavior. In: Benson DF, Blumer D (eds) Psychiatric aspects of neurologic disease. Grutton & Stratton, New York, pp 199–217
Bogdanovic MD, Mead SH, Duncan JS (2000) Aggressive behaviour at a residential epilepsy centre. Seizure 9:58–64
Bolt JMW (1970) Huntington’s Chorea in the west of Scotland. Br J Psychiatry 116:259–270
Bond A, Lader M (1988) Differential effects of oxazepam and lorazepam on aggressive responding. Psychopharmacology 95:369–373
Borbely AA (1992) Die Beeinflussung des Schlafs durch Hypnotika. In: Berger M (Hrsg) Handbuch des normalen and gestörten Schlafes. Springer, S 120–165
Bozzola FG, Gorelick PB, Freels S (1992) Personality changes in Alzheimer’s disease. Arch Neurol 49:297–300
Broughton RJ (1990) Zur Lokalisation der Schlaf-Wach-Regulierung. In: MeierEwert K, Schulz H (Hrsg) Schlaf and Schlafstörungen. Springer, Berlin, S 3–15
Brown SL (1999) Neurotransmitters and violence. In: Tardiff K (ed) Medical management of the violent patient. Marcel Dekker, New York, pp 59–86
Buckley PF (1999) The role of typical and atypical antipsychotic medication in the management of agitation and aggression. J Clin Psychiatry 60 (Suppl 10):5260
Burns A, Folstein S, Brandt J, Folstein M (1990) Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. J Nery Ment Dis 178:20–26
Cacabelos R, Rodriguez B, Carrera C, Caamano J, Beyer K, Lao JI, Sellers MA (1996) APOE-related frequency of cognitive and noncognitive symptoms in dementia. Methods Find Exp Clin Pharmacol 18:693–706
Chen JC, Borson S, Scanlan JM (2000) Stage-specific prevalence of behavioral symptoms in Alzheimer’s disease in a multi-ethnic community sample. Am J Geriatr Psychiatry 8:123–133
Clarenbach P (1992) Schlafstörungen im Rahmen neurologischer Erkrankungen. In: Berger M (Hrsg) Handbuch des normalen and gestörten Schlafes. Springer, S 329–356
Clarenbach P (2000) Parkinson’s disease and sleep. J Neurol 247 Suppl 4:IV/20–23
Colenda CC (1988) Buspirone in treatment of agitated demented patients. Lancet i:1169
Colenda CC, Cohen W, McCall WV, Rosenquist PB (1997) Phototherapy for patients with Alzheimer disease with disturbed sleep patterns: results of a community-based pilot study. Alzheimer Dis Assoc Disord 11:175–178
Conwell Y, Henderson RE (1996) Neuropsychiatry of suicide. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, pp 485–521
Craig AH, Cummings JL, Fairbanks L, Itti L, Miller BL, Li J, Mena I (1996) Cerebral blood flow correlates of apathy in Alzheimer disease. Arch Neurol 53:1116–1120
Craft M, Ismail IA, Krishnamurti D, Mathews J, Regan A, Seth RV, North PM (1987) Lithium in the treatment of aggression in mentally handicapped patients. Br J Psychiatry 150:685–689
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314
De Deyn PP, Rabheru K, Rasmussen A, Bocksberger JP, Dautzenberg PL, Eriksson S, Lawlor BA (1999) A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 53:946–955
Demerdash A, Shaalan M, Midani A, Kamel F, Bahri M (1991) Sexual behavior of a sample of females with epilepsy. Epilepsia 32:82–85
Demling J (1996) Neurobiochemie suizidalen Verhaltens. In: Wolfersdorf M, Kaschka WP (Hrsg) Suizidalität. Die biologische Dimension. Springer, Berlin, S 47–72
Derouesne C, Guigot J, Chernat V, Winchester N, Lamcomblez L (1996) Sexual behavioral changes in Alzheimer disease. Alzheimer Dis Assoc Dis 10:86–92
Derouesne C, Thibault S, Lagha-Pierucci S, Baudouin-Madec V, Ancri D, Lacomblez L (1999) Decreased awareness of cognitive deficits in patients with mild dementia of the Alzheimer type. Int J Geriatr Psychiatry 14:1019–1030
Deutsch LH, Bylsma FW, Rovner BW, Steele C, Folstein MF (1991) Psychosis and physical aggression in probable Alzheimer’s disease. Am J Psychiatry 148:11591163
Devanand DP, Brockington CD, Moody BJ, Brown RP, Mayeux R, Endicott J, Sackeim HA (1992) Behavioral syndromes in Alzheimer’s disease. Int Psychogeriatr 4 (Suppl 2):161–184
Devanand DP, Marder K, Michaels KS, Sackeim HA, Bell K, Sullivan MA, Cooper TB, Pelton GH, Mayeux R (1998) A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer’s disease. Am J Psychiatry 155:1512–1520
Dewhurst K, Oliver JE, McKnight AL (1970) Socio-psychiatric consequences of Huntington’s chorea. Br J Psychiatry 116:255–258
Diaz-Olavarrieta C, Cummings JL, Velazquez J, Garcia de la Cadena C (1999) Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 11:51–57
Dilling H, Mombour W, Schmidt MH (2000) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 3. Aufl. Huber, Bern
Dorevitch A, Katz N, Zemishlany Z, Aizenberg D, Weizman A (1999) Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior. Am J Psychiatry 156:142–144
Dose M (2000) Chorea Huntington. In: Förstl H (Hrsg) Klinische Neuro-Psychiatrie. Thieme, Stuttgart, S 242–251
Edwards JG, Anderson I (1999) Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 57:507–533
Elliott FA (1992) Violence. The neurologic contribution: an overview. Arch Neurol 49:595–603
Engelborghs S, Marien P, Pickut BA, Verstraeten S, De Deyn PP (2000) Loss of psychic self-activation after paramedian bithalamic infarction. Stroke 31:1762–1765
Erkinjuntti T, Partinen M, Sulkava R, Telakivi T, Salmi T, Tilvis R (1987) Sleep apnea in multiinfarct dementia and Alzheimer’s disease. Sleep 10:419–425
Felber W (1996) Lithiumprophylaxe and Suizidprävention. In: Wolfersdorf M, Kaschka WP (Hrsg) Suizidalität. Die biologische Dimension. Springer, Berlin, S 157–172
Ferman TJ, Boeve BF, Smith GE, Silber MH, Kokmen E, Petersen RC, Ivnik RJ (1999) REM sleep behavior disorder and dementia: cognitive differences when compared with AD. Neurology 52:951–957
Findley L, Barth JT, Powers DC, Wilhoit SC, Boyd DG, Scratt PM (1986) Cognitive impairment in patients with obstructive sleep apnea and associated hypoxemia. Chest 90:686–690
Fleischhacker WW, Miller CH, Bergmann KJ (1989) Die neuroleptikainduzierte Akathisie. Nervenarzt 60:719–723
Fleury B (1992) Sleep apnea syndrome in the elderly. Sleep 15 (6 Suppl):39–41
Foli S, Shah A (2000) Measurement of behavioural disturbance, non-cognitive symptoms and quality of life. In: O’Brien J, Ames D, Burns A (eds) Dementia, 2¡ãdedn. Arnold, London, pp 87–100
Fünfgeld EW (1970) Amantadinwirkung bei Parkinsonismus. DMW 95:1834–1836
Fuglum E, Schillinger A, Andersen JB, Belstad BE, Jensen D, Muller F, Muller KJ, Schulstad B, Elgen K (1989) Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study. Pharmatherapeutica 5:285–291
Ghika-Schmid F, Bogousslaysky J (2000) The acute behavioral syndrome of anterior thalamic infarction: a prospective study of 12 cases. Ann Neurol 48:220–227
Gilley DW, Wilson RS, Beckett LA, Evans DA (1997) Psychotic symptoms and physically aggressive behavior in Alzheimer’s disease. J Am Geriatr Soc 45:10741079
Glenn MB, Wroblewski B, Parziale J, Levine L, Whyte J, Rosenthal M (1989) Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients. Am J Phys Med Rehabil 68:221–226
Gormley N, Rizwan MR, Lovestone S (1998) Clinical predictors of aggressive behaviour in Alzheimer’s disease. Int J Geriatr Psychiatry 13:109–115
Greenberg GD, Watson RK, Deptula D (1987) Neuropsychological dysfunction in sleep apnea. Sleep 10:254–262
Greendyke RM, Kanter DR, Schuster DB, Verstraete S, Wooton J (1986) Propanolol treatment of assaultive patients with organic brain disease: a double-blind crossover, placebo-controlled study. J Nery Ment Dis 174:290–294
Gross RA, Spehlmann R, Daniels JC (1978) Sleep disturbances in progressive supranuclear palsy. Electroencephalogr Clin Neurophysiol 45:16–25
Guberman A, Stuss D (1983) The syndrome of bilateral paramedian thalamic infarction. Neurology 33:540–546
Hajak G, Rüther E, Hauri PJ (1992) Insomnie. In: Berger M (Hrsg) Handbuch des normalen and gestörten Schlafes. Springer, S 67–119
Hajak G, Rüther E (2000) Therapie von Ein-and Durchschlafstörungen. In: Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen, 2. Aufl. Thieme, Stuttgart, S 743–758
Hargrave R, Geck LC, Reed B, Mungas D (2000) Affective behavioural disturbances in Alzheimer’s disease and ischaemic vascular disease. J Neurol Neurosurg Psychiatry 68:41–46
Hawkins JW, Tinklenberg JR, Sheikh JI, Peyser CE, Yesavage JA (2000) A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. Am J Geriatr Psychiatry 8:221–225
Helgason AR, Adolfsson J, Dickman P, Arver S, Fredrikson M, Gothberg M, Steineck G (1996) Sexual desire, erection, orgasm and ejaculatory functions and their importance to elderly Swedish men: a population-based study. Age Ageing 25:285–291
Helmchen H, Müller-Oerlinghausen B (1981) Die Kombination von Antidepressiva mit anderen Medikamenten. Fortschr Neurol Psychiat 49:371–379
Hess CW (1997) Schlafstörungen and Demenz. Schweiz Rundsch Med Prax 86:1343–1349
Hirono N, Mori E, Yasuda M, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Hashimoto M, Yamashita H (1998) Factors associated with psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 64:648–652
Hoch CC, Reynolds CF, Nebes RD, Kupfer DJ, Berman SR, Campbell D (1989) Clinical significance of sleep-disordered breathing in Alzheimer’s disease. J Am Geriatr Soc 37:138–144
Hohagen F, Schönbrunn E (1992) Die Narkolepsien and andere Formen der Hypersomnie. In: Berger M (Hrsg) Handbuch des normalen and gestörten Schlafes. Springer, S 166–199
Inskip HM, Harris EC, Barraclough B (1998) Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 172:35–37
Kant R, Duffy JD, Pivovarnik (1998) Prevalence of apathy following head injury. Brain Inj 12:87–92
Keck PE Jr, Strakowski SM, McElroy SL (2000) The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. J Clin Psychiatry 61 (Suppl 3):4–9
Kertesz A, Nadkarni N, Davidson W, Thomas AW (2000) The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc 6:460–468
Köbberling J, Hintze G, Blossey HC, Dirks H, Emrich D, Mayer G, Schicha H (1981) Diagnostische Probleme der Hyperthyreose im höheren Lebensalter. DMW 106:973–978
Korpelainen JT, Nieminen P, Myllyla VV (1999) Sexual functioning among stroke patients and their spouses. Stroke 30:715–719
Kreutzer JS, Zasler ND (1989) Psychosexual consequences of traumatic brain injury: Methodology and preliminary findings. Brain Inj 3:177–186
Kunik ME, Puryear L, Orengo CA, Molinari V, Workman RH (1998) The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances. Int J Geriatr Psychiatry 13:29–34
Kuzis G, Sabe L, Tiberti C, Dorrego F, Starkstein SE (1999) Neuropsychological correlates of apathy and depression in patients with dementia. Neurology 52: 1403–1407
Lebert F, Pasquier F, Petit H (1994) Behavioral effects of trazodone in Alzheimer’s disease. J Clin Psychiatry 55:536–538
Leger JM, Moulias R, Vellas B, Monfort JC, Chapuy P, Robert P, Knellesen S, Gerard D (2000) Causes et retentissements des etats d’agitation et d’agressivite du sujet age. Encephale 26:32–43
Levine AM (1988) Buspirone and agitation in head injury. Brain injury 2:165167
Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I (1998) Apathy is not depression. J Neuropsychiatry Clin Neurosci 10:314–319
Lindenmayer JP (2000) The pathophysiology of agitation. J Clin Psychiatry 61 (Suppl 14):5–10
Lindenmayer JP, Kotsaftis A (2000) Use of sodium valproate in violent and aggressive behaviors: a critical review. J Clin Psychiatry 61:123–128
Linnoila M, Charney DS (1999) The neurobiology of aggression. In: Charney DS, Nestler EJ, Bunney BS (eds) Neurobiology of mental illness. Oxford University Press, Oxford, pp 855–871
Litvan I, Mega MS, Cummings JL, Fairbanks L (1996) Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 47:1184–1189
Litvan I, Paulsen JS, Mega MS, Cummings JL (1998) Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol 55:1313–1319
Lloyd GG (1993) Acute behaviour disturbances. J Neurol Neurosurg Psychiatry 56:1149–1156
Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC (2000) Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 157:708–714
Marin RS (1990) Differential diagnosis and classification of apathy. Am J Psychiatry 147:22–30
Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 38:143–162
Marin RS, Firinciogullari S, Biedrzycki RC (1994) Group differences in the relationship between apathy and depression. J Nery Ment Dis 182:235–239
Marin RS, Fogel BS, Hawkins J, Duffy J, Krupp B (1995) Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci 7:23–30
Mattes JA (1986) Psychopharmacology of temper outbursts. Psychopharmacol Bull 24:179–182
Matthias RE, Lubben JE, Atchison KA, Schweitzer SO (1997) Sexual activity and satisfaction among very old adults: results from a community-dwelling Medicare population survey. Gerontologist 37:6–14
McKeith IG, Grace JB, Walker Z, Byrne EJ, Wilkinson D, Stevens T, Perry EK (2000) Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. Int J Geriatr Psychiatry 15:387–392
Mega MS, Cummings JL, Fiorello T, Gornbein J (1996) The spectrum of behavioral changes in Alzheimer’s disease. Neurology 46:130–135
Mega MS, Cohenour RC (1997) Akinetic mutism: disconnection of frontal-subcortical circuits. Neuropsychiatry Neuropsychol Behav Neurol 10:254–259
Mega MS, Masterman DM, O’Connor SM, Barclay TR, Cummings JL TI (1999) The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Arch Neurol 56:1388–1393
Meier-Ewert K (1990) Schlafstörungen bei neurologischen Erkrankungen. In: Meier-Ewert K, Schulz H (Hrsg) Schlaf and Schlafstörungen. Springer, Berlin, S 84–95
Mendez MF, Martin RJ, Smyth KA, Whitehouse PJ (1990) Psychiatric symptoms associated with Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 2:28–33
Mimura K, Harada M, Sumiyoshi S, Tohya G, Takagi M, Fujita E, Takata A, Tatetsu S (1999) Long-term follow-up study on sequelae of carbon monoxide poisoning; serial investigation 33 years after poisoning. Seishin Shinkeigaku Zasshi 101:592–618
Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K (1994) Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand 89:1–7
Monga TN, Lawson JS, Inglis J (1986) Sexual dysfunction in stroke patients. Arch Phys Med Rehabil 67:19–22
Morrell MJ (1991) Sexual dysfunction in epilepsy. Epilepsia 32, Suppl 6:38–45
Müller-Oerlinghausen B (1992) Pharmakotherapeutische Ansätze bei Aggression. In:Müller H-J, Van Praag HM (Hrsg) Aggression and Autoaggression. Springer, Berlin, S 113–120
Müller-Oerlinghausen B, Grof P, Schou M (1999) Lithium and suicide prevention. Br J Psychiatry 175:90–91
Mulligan T, Retchin SM, Chinchilli VM, Bettinger CB (1988) The role of aging and chronic disease in sexual dysfunction. J Am Geriatr Soc 36:520–524
Murakami Y, Kato Y (1998) Sleep disorders in several pathologic states - endocrine diseases. Nippon Rinsho 56:457–460
Nygaard H, Bakke K, Brudvik E, Lien GK, Moe TJ, Elgen K (1988) Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study. Pharmatherapeutica 5:152–158
Nygaard HA, Bakke K, Brudvik E, Elgen K, Lien GK (2000) Dosing of neuroleptics in elderly demented patients with aggressive and agitated behaviour: a double-blind study with zuclopenthixol. Curr Med Res Opin 13:222–232
Ott BR, Tate CA, Gordon NM, Heindel WC (1996) Gender differences in the behavioral manifestations of Alzheimer’s disease. J Am Geriatr Soc 44:583–587
Ott BR, Noto RB, Fogel BS (1996) Apathy and loss of insight in Alzheimer’s disease: a SPECT imaging study. J Neuropsychiatry Clin Neurosci 8:41–46
Otto A, Zerr I, Lantsch M, Weidehaas K, Riedemann C, Poser S (1998) Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 64:524–528
Padoani W, Dello Buono M, Marietta P, Scocco P, Zaghi PC, De Leo D (2000) Influence of cognitive status on the sexual life of 352 elderly italians aged 65–105 years. Gerontology 46:258–265
Palacios A, Cohen MA, Cobbs R (1991) Apathetic hyperthyroidism in middle age. Int J Psychiatry Med 21:393–400
Palomaki H, Partinen M, Erkinjuntti T, Kaste M (1992) Snoring, sleep apnea syndrome, and stroke. Neurology 42 (7 Suppl 6):75–81
Pekrun R (1990) Motivation: Klassifikation und Diagnostik. In: Baumann U, Perrez M (Hrsg) Lehrbuch Klinische Psychologie, Band 1. Huber, Bern, S 111–113
Pfaus JG, Everitt BJ (1995) The psychopharmacology of sexual behavior. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology. The4thgeneration of progress. Raven Press, New York, pp 743–758
Pillar G, Lavie P (1998) Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. Chest 114:697–703
Pinner E, Rich CL (1988) Effects of trazodone on aggressive behavior in seven patients with organic mental disorders. Am J Psychiatry 145:1295–1296
Ploog D (1993) Psychopathologische Prozesse in neuroethologischer Sicht. In:Schüttler R(Hrsg) Organische Psychosyndrome. Springer, Berlin, S 1–28
Pollmächer T, Lauer C (1992) Physiologie von Schlaf und Schlafregulation. In: Berger M (Hrsg) Handbuch des normalen und gestörten Schlafes. Springer, S 1–44
Prinz PN, Peskind ER, Vitaliano PP, Raskind MA, Eisdorfer C, Zemcuznikov N, Gerber CJ (1982) Changes in the sleep and waking EEGs of nondemented and demented elderly subjects. J Am Geriatr Soc 30:86–93
Rainer M, Mucke HA, Masching A, Haushofer M (1999) Nichtkognitive Symptomprofile bei Demenzpatienten. Erfahrungen aus Psychiatrie, Ambulanz und Memory-Clinic. Psychiatr Prax 26:71–75
Rao N, Jelline HM, Woolston DC (1985) Agitation in closed head injury: haloperidol effects on rehabilitation outcome. Arch Phys Med Rehabil 66:30–34
Razmy A, Shapiro CM (2000) Interactions of sleep and Parkinson’s disease. Semin Clin Neuropsychiatry 5:20–32
Reisberg B, Borenstein J, Salob S, Ferris S, Fransson E, Georgotas A (1987) Behavioural symptoms in Alzheimer’s disease: phenomenology and treatment. J Clin Psychiatry 48 (Suppl):9–15
Röhle K-H (1992) Internistische Erkrankungen und Schlafstörungen. In: Berger M (Hrsg) Handbuch des normalen und gestörten Schlafes. Springer, S 243–267
Rudolf GAE (2000) Therapieschemata Psychiatrie, 3. Aufl. Urban & Schwarzenberg, München
Sabhesan S, Natarajan M (1989) Sexual behavior after head injury in Indian men and women. Arch Sex Behav 18:349–356
Salzman C, Solomon D, Miyawaki E, Glassman R, Rood L, Flowers E, Thayer S (1991) Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. J Clin Psychiatry 52:177–180
Saß H, Wittchen H-U, Zaudig M (Hrsg) (2000) Diagnostisches und statistisches Manual psychischer Störungen DSM-IV, 3. Aufl. Hogrefe, Göttingen
Saver JL, Salloway SP, Devinsky O, Bear DM (1996) Neuropsychiatry of aggression. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, pp 523–548
Schenck CH, Mahowald MW, Anderson ML, Silber MH, Boeve BF, Parisi JE (1997) Lewy body variant of Alzheimer’s disease (AD) identified by postmortem ubiquitin staining in a previously reported case of AD associated with REM sleep behavior disorder. Biol Psychiatry 42:527–528
Schifter R (1985) Sexualorgane. In: Schifter R (Hrsg) Neurologie des vegetativen Systems. Springer, Berlin, S 101–118
Schlegel S (2001) Pharmakotherapie aggressiver Störungen. In:Hartwich P, Haas S(Hrsg) Aggressive Störungen psychiatrisch Kranker. Verlag Wissenschaft & Praxis, Sternenfels, S 97–110
Schneider B, Wetterling T (2001) Biologische Grundlagen der Aggression. In: Hartwich P, Haas S (Hrsg) Aggressive Störungen psychiatrisch Kranker. Verlag Wissenschaft & Praxis, Sternenfels, S 27–49
Schramm E (1992) Psychodiagnostische Erfassung von Schlafstörungen. In: Berger M (Hrsg) Handbuch des normalen und gestörten Schlafes. Springer, S 45–66
Schwab RS, England AC, Poskaner DC (1969) Amantadine in the treatment of Parkinson’s disease. JAMA 208:1168–1170
Segraves RT (1996) Neuropsychiatric aspects of sexual dysfunction. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, pp 757–771
Seidel M (1989) Phänomenologie und Therapie der Neuroleptika-induzierten Akathisie - eine Literaturübersicht. Fortschr Neurol Psychiat 57:489–494
Sellers J, Tyrer P, Whiteley A, Banks DC, Barer DH (1982) Neurotoxic effects of lithium with delayed rise in serum lithium levels. Br J Psychiatry 140:623–625
Shankle WR, Nielson KA, Cotman CW (1995) Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients. Alzheimer Dis Assoc Disord 9:233–237
Sheard MH (1988) Clinical pharmacology of aggressive behaviour. Clin Neuropharmacol 11:483–492
Shukla GD, Srivastava ON, Katiyar BC (1979) Sexual disturbances in temporal lobe epilepsy: a controlled study. Br J Psychiatry 134:288–292
Silver JM, Hales RE, Yudofsky SC (1994) Neuropsychiatric aspects of traumatic brain injury. In: Yudofsky SC, Hales RE (eds) Synopsis of neuropsychiatry. American Psychiatric Press, Washington DC, S 280–306
Silver JM, Yudofsky SC, Slater JA, Gold RK, Stryer BL, Williams DT, Wolland H, Endicott J (1999) Propranolol treatment of chronically hospitalized aggressive patients. J Neuropsychiatry Clin Neurosci 11:328–335
Simpson DM, Foster D (1986) Improvement in organically disturbed behavior with trazodone treatment. J Clin Psychiatry 47:191–193
Sjögren K, Fugl-Meyer AR (1982) Adjustment to life after stroke with special reference to sexual intercourse and leisure. J Psychosom Res 26:409–417
Spector JP, Carey MP (1990) Incidence and prevalence of sexual dysfunctions. A critical review of empirical literature. Arch sex Behav 19:389–408
Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4:134–139
Starkstein SE, Sabe L, Chemerinski E, Jason L, Leiguarda R (1996) Two domains of anosognosia in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 61:485490
Starkstein SE, Sabe L, Vazquez S, Di Lorenzo G, Martinez A, Petracca G, Teson A, Chemerinski E, Leiguarda R (1997) Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 63:66–73
Steinert T (1992) Neuere Tendenzen in der Pharmakotherapie aggressiven Verhaltens bei psychisch Kranken. Fortschr Neurol Psychiat 60:393–400
Steinert T, Wolfersdorf M (1993) Aggression und Autoaggression. Psychiat Prax 20:1–8
Steinert T, Wölfe M, Gebhardt RP (2000) Measurement of violence during in-patient treatment and association with psychopathology. Acta Psychiatr Scand 102:107–112
Stenager EN, Stenager E (1992) Suicide and patients with neurologic diseases. Methodologic problems. Arch Neurol 49:1296–1303
Stenager EN, Koch-Henriksen N, Stenager E (1996) Risk factors for suicide in multiple sclerosis. Psychother Psychosom 65:86–90
Stoppe G, Brandt CA, Staedt JH (1999) Behavioural problems associated with dementia: the role of newer antipsychotics. Drugs Aging 14:41–54
Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A (2000) Olanzapine treatment of psychotic and behavioral symptoms with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 57:968–976
Tariot PN, Erb R, Podgorski CA, Cox C, Patel S, Jakimovich L, Irvine C (1998) Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 155:54–61
Tiller JWG, Dakis JA, Sha JM (1988) Short-term buspirone treatment in disinhibition with dementia. Lancet ii:510
Tsai SJ, Hwang JP, Yang CH, Liu KM, Lirng JF (1999) Inappropriate sexual behaviors in dementia: a preliminary report. Alzheimer Dis Assoc Disord 13:60–62
Ulrich G, Gschwilm R (1987) Vigilanz - Ordnungszustand oder ordnende Kraft? Fortschr Neurol Psychiatr 56:398–402
Van Reekum R, Bayley M, Garner S, Burke IM, Fawcett S, Hart A, Thompson W (1995) N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. Brain Inj 9:49–53
Warner J (2000) Sexuality and dementia. In: O’Brien J, Ames D, Burns A (eds) Dementia, 2nd edn. Arnold, London, pp 267–271
Wetterling T (1994) Differentialdiagnose dementieller Abbauprozesse. Thieme, Stuttgart
Wetterling T (1995) Schlafstörungen bei psychiatrischen Patienten. Nervenheilkunde 14:415–421
Wetterling T (2001) Bodyweight gain with atypical antipsychotics - a comparative review. Drugs Safety 24:59–73
Wetterling T (2001) Psychiatrische Notfälle. In: Braun J, Preuss R (Hrsg) Leitfaden Intensivmedizin, 5. Aufl. Urban & Fischer, Stuttgart
Wetterling T (2001) Hirnorganische Störungen als Ursache sexueller Störungen. In: Hartwich P, Haas S (Hrsg) Sexuelle Störungen bei psychisch Kranken. Verlag Wissenschaft und Praxis, Sternenfels
Wiegand M, Möller AA, Lauer CJ, Stolz S, Schreiber W, Dose M, Krieg JC (1991) Nocturnal sleep in Huntington’s disease. J Neurol 238:203–208
Wolfersdorf M (1995) Suizidalität - Begriffsbestimmung und Entwicklungsmodelle suizidalen Verhaltens. In: Wolfersdorf M, Kaschka WP (Hrsg) Suizidalität. Die biologische Dimension. Springer, Berlin, S 1–16
Wolfersdorf M (2000) Therapie der Suizidalität. In: Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen, 2. Aufl. Thieme, Stuttgart, S 1098–1115
Wright LK (1991) The impact of Alzheimer’s disease on the marital relationship. Gerontologist 31:224–237
Wroblewski BA, Joseph AB, Kupfer J, Kalliel K (1997) Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury. Brain Inj 11:37–47
Zeidler M, Stewart GE, Barraclough CR, Bateman DE, Bates D, Burn DJ, Colchester AC, Durward W, Fletcher NA, Hawkins SA, Mackenzie JM, Will RG (1997) New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 350:903–907
Zeiss AM, Davies HD, Wood M, Tinklenberg JR (1990) The incidence and correlates of erectile problems in patients with Alzheimer’s disease. Arch Sex Behav 19:325–331
Zencius A, Wesolowski MD, Burke WH, Hough S (1990) Managing hypersexual disorders in brain-injured clients. Brain Inj 4:175–181
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wetterling, T. (2002). Verhaltensauffälligkeiten und andere Störungen. In: Organische psychische Störungen. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57532-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-57532-7_6
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63288-4
Online ISBN: 978-3-642-57532-7
eBook Packages: Springer Book Archive